TABLE 2:

P values from the post-hoc comparisons

ComparisonP Value
No. of enhancing lesions
 Between SD and DD.068*
 Between SD and TD.012
 Between DD and TD.018
Total enhancing area
 Between SD and DD.043
 Between SD and TD.008
 Between DD and TD.012
Mean CNR
 Between SD and DD.063*
 Between SD and TD.011
 Between DD and TD.028

  • Note—SD indicates a single dose (0.1 mmol/kg) of gadodiamide; DD, double dose (0.2 mmol/kg) of gadodiamide; and TD, triple dose (0.3 mmol/kg) of gadodiamide.

  • * Not significant.